The objective of this study is to evaluate efficacy and safety of soluble beta-1,3/1,6-glucan (SBG) on chronic diabetic foot ulcers.
Evaluation of efficacy and safety of SBG vs placebo in the treatment of chronic diabetic foot ulcers.